Sentinel lymph node biopsy for DCIS: Are we approaching consensus?

被引:9
作者
Cody, Hiram S., III [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA
关键词
D O I
10.1245/s10434-006-9300-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2179 / 2181
页数:3
相关论文
共 24 条
[21]   The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ [J].
Tamhane, R ;
Dahlstrom, JE ;
McCallum, DD ;
Buckingham, JM .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) :999-1003
[22]   An update of sentinel lymph node mapping in patients with ductal carcinoma in situ [J].
Wilkie, C ;
White, L ;
Dupont, E ;
Cantor, A ;
Cox, CE .
AMERICAN JOURNAL OF SURGERY, 2005, 190 (04) :563-566
[23]   Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer [J].
Xing, Y. ;
Foy, M. ;
Cox, D. D. ;
Kuerer, H. M. ;
Hunt, K. K. ;
Cormier, J. N. .
BRITISH JOURNAL OF SURGERY, 2006, 93 (05) :539-546
[24]   Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ [J].
Yen, TWF ;
Hunt, KK ;
Ross, MI ;
Mirza, NQ ;
Babiera, GV ;
Meric-Bernstarn, F ;
Singletary, SE ;
Symmans, WF ;
Giordano, SH ;
Feig, BW ;
Ames, FC ;
Kuerer, HM .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (04) :516-526